The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Eugenol: A Phyto-Compound Effective against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Strain Biofilms
Open accessAbstract
BACKGROUND: Inhibition and eradication of Staphylococcus aureus biofilms with conventional antibiotic is difficult, and the treatment is further complicated by the rise of antibiotic resistance among staphylococci. Consequently, there is a need for novel antimicrobials that can treat biofilm-related infections and decrease antibiotics burden. Natural compounds such as eugenol with anti-microbial properties are attractive agents that could reduce the use of conventional antibiotics. In this study we evaluated the effect of eugenol on MRSA and MSSA biofilms in vitro and bacterial colonization in vivo. METHODS AND RESULTS: Effect of eugenol on in vitro biofilm and in vivo colonization were studied using microtiter plate assay and otitis media-rat model respectively. The architecture of in vitro biofilms and in vivo colonization of bacteria was viewed with SEM. Real-time RT-PCR was used to study gene expression. Check board method was used to study the synergistic effects of eugenol and carvacrol on established biofilms. Eugenol significantly inhibited biofilms growth of MRSA and MSSA in vitro in a concentration-dependent manner. Eugenol at MIC or 2×MIC effectively eradicated the pre-established biofilms of MRSA and MSSA clinical strains. In vivo, sub-MIC of eugenol significantly decreased 88% S. aureus colonization in rat middle ear. Eugenol was observed to damage the cell-membrane and cause a leakage of the cell contents. At sub-inhibitory concentration, it decreases the expression of biofilm-and enterotoxin-related genes. Eugenol showed a synergistic effect with carvacrol on the eradication of pre-established biofilms. CONCLUSION/MAJOR FINDING: This study demonstrated that eugenol exhibits notable activity against MRSA and MSSA clinical strains biofilms. Eugenol inhibited biofilm formation, disrupted the cell-to-cell connections, detached the existing biofilms, and killed the bacteria in biofilms of both MRSA and MSSA with equal effectiveness. Therefore, eugenol may be used to control or eradicate S. aureus biofilm-related infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“It is one of the most common pathogens implicated in a wide variety of biofilm-related infections, including infections involving implanted medical devices such as bloodline catheters and heart implants, and infections associated with cystic fibrosis, wounds, superficial skin infections, and otitis media [2,3,4,5,6].”
BackgroundEssential oils: Their antibacterial properties and potential applications in foods—A review
Burt, S. (2004) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2004.03.022 · Cited by 10,488
Biological effects of essential oils—A review
Bakkali, F., Averbeck, S., Averbeck, D., & Idaomar, M. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.09.106 · Cited by 7,929
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Biofilms: Microbial Life on Surfaces
Donlan, R. M. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0809.020063 · Cited by 4,145
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M., & Beachey, E. H. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.996-1006.1985 · Cited by 2,255
Hyldgaard, M., Mygind, T., & Meyer, R. L. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00012 · Cited by 2,191
Characterization of the action of selected essential oil components on Gram-negative bacteria
Helander, I. M., Alakomi, H.-L., Latva-Kala, K., Mattila-Sandholm, T., Pol, I., Smid, E. J., Gorris, L. G. M., & von Wright, A. (1998) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf980154m · Cited by 1,664
Maki, D. G., Kluger, D. M., & Crnich, C. J. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1159 · Cited by 1,549
Cramton, S. E., Gerke, C., Schnell, N. F., Nichols, W. W., & Götz, F. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5427-5433.1999 · Cited by 1,124
Devi, K. P., Nisha, S. A., Sakthivel, R., & Pandian, S. K. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.04.025 · Cited by 893
Mack, D., Fischer, W., Krokotsch, A., Leopold, K., Hartmann, R., Egge, H., & Laufs, R. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.175-183.1996 · Cited by 885
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Inouye, S., Takizawa, T., & Yamaguchi, H. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.565 · Cited by 786
Mechanisms of Action of Carvacrol on the Food-Borne Pathogen Bacillus cereus
Ultee, A., Kets, E. P. W., & Smid, E. J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.10.4606-4610.1999 · Cited by 781
Global Gene Expression in Staphylococcus aureus Biofilms
Beenken, K. E., Dunman, P. M., McAleese, F., Macapagal, D., Murphy, E., Projan, S. J., Blevins, J. S., & Smeltzer, M. S. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4665-4684.2004 · Cited by 582
Nostro, A., Roccaro, A. S., Bisignano, G., Marino, A., Cannatelli, M. A., Pizzimenti, F. C., Cioni, P. L., Procopio, F., & Blanco, A. R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46804-0 · Cited by 558
SarA and not σB is essential for biofilm development by Staphylococcus aureus
Valle, J., Toledo‐Arana, A., Berasain, C., Ghigo, J., Amorena, B., Penadés, J. R., & Lasa, I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03493.x · Cited by 442
Gill, A. O., & Holley, R. A. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.5750-5755.2004 · Cited by 439
Mutation of sarA in Staphylococcus aureus Limits Biofilm Formation
Beenken, K. E., Blevins, J. S., & Smeltzer, M. S. (2003) · Infection and Immunity · doi:10.1128/iai.71.7.4206-4211.2003 · Cited by 429
Pili in Gram-positive bacteria: assembly, involvement in colonization and biofilm development
Mandlik, A., Swierczynski, A., Das, A., & Ton-That, H. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.10.010 · Cited by 402
O'Neill, E., Pozzi, C., Houston, P., Smyth, D., Humphreys, H., Robinson, D. A., & O'Gara, J. P. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02280-06 · Cited by 349
Synergistic effect between clove oil and its major compounds and antibiotics against oral bacteria
Moon, S.-E., Kim, H.-Y., & Cha, J.-D. (2011) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2011.02.005 · Cited by 320
Petersen, P. J., Labthavikul, P., Jones, C. H., & Bradford, P. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki477 · Cited by 291
Synergistic interaction of eugenol with antibiotics against Gram negative bacteria
Hemaiswarya, S., & Doble, M. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.04.006 · Cited by 270
Burt, S. A., Ojo-Fakunle, V. T. A., Woertman, J., & Veldhuizen, E. J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093414 · Cited by 263
Quave, C. L., Estévez-Carmona, M., Compadre, C. M., Hobby, G., Hendrickson, H., Beenken, K. E., & Smeltzer, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028737 · Cited by 211
Vergara-Irigaray, M., Valle, J., Merino, N., Latasa, C., García, B., Ruiz de los Mozos, I., Solano, C., Toledo-Arana, A., Penadés, J. R., & Lasa, I. (2009) · Infection and Immunity · doi:10.1128/iai.00616-09 · Cited by 204
Kwieciński, J., Eick, S., & Wójcik, K. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.08.028 · Cited by 181
Biofilms, Infection, and Antimicrobial Therapy
(2005) · CRC Press eBooks · doi:10.1201/9781420028232 · Cited by 165
La Storia, A., Ercolini, D., Marinello, F., Di Pasqua, R., Villani, F., & Mauriello, G. (2011) · Research in Microbiology · doi:10.1016/j.resmic.2010.11.006 · Cited by 156 · cited 1×
“Carvacrol is a phenolic monoterpenoid and a major constituent of oregano, which has been reported to disintegrate the outer membrane of bacteria [49,50].”
BackgroundExploiting current understanding of antibiotic action for discovery of new drugs
Chopra, I., Hesse, L., & O’Neill, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.13.x · Cited by 154
Factors Contributing to the Biofilm-Deficient Phenotype of Staphylococcus aureus sarA Mutants
Tsang, L. H., Cassat, J. E., Shaw, L. N., Beenken, K. E., & Smeltzer, M. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003361 · Cited by 129
Eugenol Reduces the Expression of Virulence-Related Exoproteins in Staphylococcus aureus
Qiu, J., Feng, H., Lü, J., Xiang, H., Wang, D., Dong, J., Wang, J., Wang, X., Liu, J., & Deng, X. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00704-10 · Cited by 128
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Thornton, R. B., Wiertsema, S. P., Kirkham, L. S., Rigby, P. J., Vijayasekaran, S., Coates, H. L. C., & Richmond, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053837 · Cited by 120
Mohammed, M. J., & Al-Bayati, F. A. Y. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.12.026 · Cited by 106
Medical significance and management of staphylococcal biofilm
Agarwal, A., Singh, K. P., & Jain, A. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00601.x · Cited by 104
Novel Inhibitors of Staphylococcus aureus Virulence Gene Expression and Biofilm Formation
Ma, Y., Xu, Y., Yestrepsky, B. D., Sorenson, R. J., Chen, M., Larsen, S. D., & Sun, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047255 · Cited by 100
van Alphen, L. B., Burt, S. A., Veenendaal, A. K. J., Bleumink‐Pluym, N. M. C., & van Putten, J. P. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045343 · Cited by 77
Hammer, K. A., & Fuller, K. A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.05.015 · Cited by 74
Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In Vivo
Weiss, E. C., Zielinska, A., Beenken, K. E., Spencer, H. J., Daily, S. T., & Smeltzer, M. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00484-09 · Cited by 70
Looking toward basic science for potential drug discovery targets against community‐associated MRSA
Otto, M. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20160 · Cited by 54
Hashimoto, S., Uchiyama, K., Maeda, M., Ishitsuka, K., FURUMOTO, K., & Nakamura, Y. (1988) · Journal of Dental Research · doi:10.1177/00220345880670080601 · Cited by 46
Nostro, A., Cellini, L., Zimbalatti, V., Blanco, A. R., Marino, A., Pizzimenti, F., Giulio, M. D., & Bisignano, G. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02928.x · Cited by 42
Yadav, M., Park, S., Chae, S., Song, J., & Kim, H. C. (2013) · Apmis · doi:10.1111/apm.12067 · Cited by 40
Self-citationKristinsson, K. G., Magnúsdóttir, A. B., Petersen, H., & Hermansson, A. (2005) · The Journal of Infectious Diseases · doi:10.1086/430003 · Cited by 35
Snowden, J. N., Beaver, M., Beenken, K., Smeltzer, M., Horswill, A. R., & Kielian, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084089 · Cited by 34
Yadav, M., Chae, S. W., & Song, J. (2012) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2012.5.3.139 · Cited by 25
Self-citationEconomic Impact of Biofilms on Treatment Costs
Rinde, H., Thomas, J., & Litton, I. (2005) · CRC Press eBooks · doi:10.1201/9781420028232-6 · Cited by 19
Cited by
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint
Marchese, A., Barbieri, R., Coppo, E., Orhan, I. E., Daglia, M., Nabavi, S. F., Izadi, M., Abdollahi, M., Nabavi, S. M., & Ajami, M. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1295225 · Cited by 750
Plant Natural Products Targeting Bacterial Virulence Factors
Silva, L. N., Zimmer, K. R., Macedo, A. J., & Trentin, D. S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00184 · Cited by 504
Essential oil eugenol: Sources, extraction techniques and nutraceutical perspectives
Khalil, A. A., Rahman, U. U., Khan, M. R., Sahar, A., Mehmood, T., & Khan, M. (2017) · RSC Advances · doi:10.1039/c7ra04803c · Cited by 407
Exploring phytochemicals for combating antibiotic resistance in microbial pathogens
Khare, T., Anand, U., Dey, A., Assaraf, Y. G., Chen, Z.-S., Liu, Z., & Kumar, V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720726 · Cited by 281
Metadata
- Authors
- Yadav, M. K., Chae, S.-W., Im, G. J., Chung, J.-W., & Song, J.-J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-17
- Volume
- 10
- Issue
- 3
- Pages
- e0119564
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1985372050
- Cited by
- 258
- References
- 53
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.